Vical Receives US Patent for Cytomegalovirus Vaccines
This new patent covers DNA vaccines containing codon-optimized versions of genes encoding gB and CMV phosphoprotein 65 antigens, formulated with Vical’s Vaxfectin adjuvant.
Read MorePosted by Clinical Lab Products | Feb 20, 2011 | Cancer, Miscellaneous |
This new patent covers DNA vaccines containing codon-optimized versions of genes encoding gB and CMV phosphoprotein 65 antigens, formulated with Vical’s Vaxfectin adjuvant.
Read MorePosted by Clinical Lab Products | Feb 5, 2011 | Cancer, Miscellaneous, Printers |
Data Unlimited International Inc Innovatum IncThermo Fisher ScientificTypenexZebra Technologies Corp
Read MorePosted by Clinical Lab Products | Feb 2, 2011 | Hematology & Serology, Serology Instrumentation |
As a field, serology has been steady, with a push in innovative automation, ease of use, and evaluation of assasy and results.
Read MorePosted by Clinical Lab Products | Feb 1, 2011 | Cancer, Miscellaneous, Pancreatic |
Personalized medicine, one goal of molecular diagnostics that is already being clinically realized, offers the opportunity to treat individuals with greater efficacy and efficiency than ever before.
Read MorePosted by Clinical Lab Products | Jan 31, 2011 | Miscellaneous |
Amsteradam Molecular Therapeutics will receive a third of a 3.3-million pound European Union consortium grant for the development of a gene therapy product for Acute Intermittent Porphyria.
Read More